Literature DB >> 782601

Retinal vaso-occlusion in sickling hemoglobinopathies.

M F Goldberg.   

Abstract

Sickle cell retinopathy, in all of its manifestations, represents the effects of arteriolar and capillary occlusions. Increased viscosity of circulating whole blood plus the microembolic action of individual sickled erythrocytes contribute to vasoocclusion. Decreased oxygenation and increased acidosis develop and lead to further sickling -- and further vaso-occlusion. The cycle of erythrostasis that characterizes sickling throughout the body is also applicable to the retina. The transparent media of the eye permit direct visualization of vaso-occlusions which occur preferentially in and about the macula and in the far periphery of the retina. Many of the occlusive episodes are transient. There dynamic events are simultaneously occurring elsewhere in the body but can only be visualized in the eye. The net effect in the retina is a remodeling of its vasculature, as some vessels close and others reopen. After the onset of arteriolar closure in the retina, affected blood vessels embark on a spontaneous, naturally evolving course of events leading to arteriolarvenular anastomoses, neovascular proliferations, vitreous hemorrhages, and retinal detachment. The advanced stages of proliferative sickle retinopathy are most commonly observed in SC disease and in Sthal, possibly because these two forms of sickling have significantly higher than normal whole blood viscosity. Retinal vaso-occlusions can also lead to blow-out hemorrhages which may evolve into salmon patches, iridescent spots, schisis cavities, and black sunbursts. In some respects sickle retinopathy is unique, but many of its manifestations are similar to those of retinopathies found in diabetes mellitus, AC hemoglobinopathy, Takayasu pulseless disease, sarcoidosis, chronic myelogenous leukemia, branch retinal vein occlusion, retrolental fibroplasia, and Eales disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 782601

Source DB:  PubMed          Journal:  Birth Defects Orig Artic Ser        ISSN: 0547-6844


  12 in total

1.  Human bulbar conjunctival hemodynamics in hemoglobin SS and SC disease.

Authors:  Justin Wanek; Bruce Gaynes; Jennifer I Lim; Robert Molokie; Mahnaz Shahidi
Journal:  Am J Hematol       Date:  2013-06-12       Impact factor: 10.047

2.  Macular blood flow velocity in sickle cell disease: relation to red cell density.

Authors:  M S Roy; P Gascon; D Giuliani
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

3.  Conjunctival microvascular haemodynamics in sickle cell retinopathy.

Authors:  Ali Kord Valeshabad; Justin Wanek; Ruth Zelkha; Jennifer I Lim; Nicole Camardo; Bruce Gaynes; Mahnaz Shahidi
Journal:  Acta Ophthalmol       Date:  2014-11-27       Impact factor: 3.761

4.  Severe proliferative retinopathy is associated with blood hyperviscosity in sickle cell hemoglobin-C disease but not in sickle cell anemia.

Authors:  Clément Lemaire; Yann Lamarre; Nathalie Lemonne; Xavier Waltz; Sadri Chahed; Florence Cabot; Ioana Botez; Benoit Tressieres; Marie-Laure Lalanne-Mistrih; Maryse Etienne-Julan; Philippe Connes
Journal:  Clin Hemorheol Microcirc       Date:  2013-01-01       Impact factor: 2.375

5.  The diagnosis and treatment of sickled erythrocytes in human hyphemas.

Authors:  M F Goldberg
Journal:  Trans Am Ophthalmol Soc       Date:  1978

6.  Retinal and choroidal neovascularization in a transgenic mouse model of sickle cell disease.

Authors:  G A Lutty; D S McLeod; A Pachnis; F Costantini; M E Fabry; R L Nagel
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

7.  Imaging Foveal Microvasculature: Optical Coherence Tomography Angiography Versus Adaptive Optics Scanning Light Ophthalmoscope Fluorescein Angiography.

Authors:  Shelley Mo; Brian Krawitz; Eleni Efstathiadis; Lawrence Geyman; Rishard Weitz; Toco Y P Chui; Joseph Carroll; Alfredo Dubra; Richard B Rosen
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

8.  Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy.

Authors:  Kathleen Jee; Murilo Rodrigues; Fabiana Kashiwabuchi; Brooks P Applewhite; Ian Han; Gerard Lutty; Morton F Goldberg; Gregg L Semenza; Silvia Montaner; Akrit Sodhi
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

9.  Sickle cell disease retinopathy: characterization among pediatric and teenage patients from northeastern Brazil.

Authors:  Dayse Cury de Almeida Oliveira; Magda O S Carvalho; Valma Maria Lopes do Nascimento; Flávia Silva Villas-Bôas; Bernardo Galvão-Castro; Marilda Souza Goncalves
Journal:  Rev Bras Hematol Hemoter       Date:  2014-07-18

10.  Expression Pattern of HIF-1α and VEGF Supports Circumferential Application of Scatter Laser for Proliferative Sickle Retinopathy.

Authors:  Murilo Rodrigues; Fabiana Kashiwabuchi; Monika Deshpande; Kathleen Jee; Morton F Goldberg; Gerard Lutty; Gregg L Semenza; Silvia Montaner; Akrit Sodhi
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-12-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.